Factors predicting the prognosis of oral alendronate-related osteonecrosis of the jaws: a 4-year cohort study.

Lee, Jang-Jaer

Factors predicting the prognosis of oral alendronate-related osteonecrosis of the jaws: a 4-year cohort study. [electronic resource] - Head & neck Dec 2013 - 1787-95 p. digital

Publication Type: Journal Article

1097-0347

10.1002/hed.23235 doi


Adult
Aged
Aged, 80 and over
Alendronate--adverse effects
Alkaline Phosphatase--blood
Amoxicillin--therapeutic use
Amoxicillin-Potassium Clavulanate Combination--therapeutic use
Anti-Bacterial Agents--therapeutic use
Biomarkers--blood
Bisphosphonate-Associated Osteonecrosis of the Jaw--pathology
Bone Density Conservation Agents--adverse effects
Bone Remodeling
Chlorhexidine--therapeutic use
Clindamycin--therapeutic use
Cohort Studies
Collagen Type I--blood
Debridement
Female
Humans
Male
Middle Aged
Mouthwashes--therapeutic use
Multivariate Analysis
Osteoporosis--drug therapy
Peptides--blood
Prognosis
Retrospective Studies